Cargando…
COVID-19 vaccines and global stock markets
Global stock markets react positively when different phases of human clinical trials on COVID-19 vaccines begin. The average abnormal stock return on the first day of the trials is both statistically and economically significant at 8.08 basis points. The increase in the average abnormal stock return...
Autores principales: | Chan, Kam Fong, Chen, Zhuo, Wen, Yuanji, Xu, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898767/ https://www.ncbi.nlm.nih.gov/pubmed/35283695 http://dx.doi.org/10.1016/j.frl.2022.102774 |
Ejemplares similares
-
Covid-19 vaccine approvals and stock market returns: The case of Chinese stocks
por: Ho, Ken C., et al.
Publicado: (2022) -
The stock market reaction to COVID-19 vaccination in ASEAN
por: Herlina, Marizsa, et al.
Publicado: (2023) -
Contagion in Global Stock Markets during the COVID‐19 Crisis
por: Fu, Shenze, et al.
Publicado: (2021) -
Stock market reactions to COVID-19 lockdown: A global analysis
por: Scherf, Matthias, et al.
Publicado: (2022) -
Analysis of global stock markets’ connections with emphasis on the impact of COVID-19()
por: Guo, Hongfeng, et al.
Publicado: (2021)